InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Kiniksa Pharmaceuticals International, plc

KNSA Clue Score67
Fiscal year ends December CIK 0001730430 Results filed 27 Oct 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

11
Insider
Date
Role
Action
Shares
Price
Amount
Michael R Megna
3 Sep 2026
Chief Accounting Officer
Sold on a plan
4,600
$80.30
$369.38K
Ross Moat
9 Apr 2026
Chief Operating Officer
Sold on a plan
1,703
$46.69
$79.51K
Michael R Megna
9 Apr 2026
Chief Accounting Officer
Sold on a plan
6,625
$46.69
$309.32K
Ross Moat
6 Apr 2026
Chief Operating Officer
Sold on a plan
2,367
$48.58
$114.99K
Mark Ragosa
8 Jan 2026
Chief Financial Officer
Sold on a plan
12,000
$41.89
$502.68K
Ross Moat
4 Sep 2025
Chief Corp. & Comm. Officer
Sold on a plan
3,523
$35.31
$124.40K
Ross Moat
21 Apr 2025
Chief Commercial Officer
Sold on a plan
18,259
$20.29
$370.48K
Sanj K Patel
7 Mar 2024
Chairman & CEO
Sold on a plan indirect
65,012
$21.02
$1.37M
Sanj K Patel
6 Mar 2024
Chairman & CEO
Sold on a plan indirect
5,582
$21.00
$117.22K
Sanj K Patel
4 Mar 2024
Chairman & CEO
Sold on a plan indirect
3,336
$22.00
$73.39K
Sanj K Patel
4 Mar 2024
Chairman & CEO
Sold on a plan indirect
9,406
$21.31
$200.44K
Show all 237 transactions →

What was left out

Form 4 filings counted 358
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 16
Sales on a Rule 10b5-1 plan 11
Sales straight out of an exercise 205
Sales at will 8
Transactions with no price 0
Shares from compensation/vesting 8,216,831
Sales filed before the plan box existed 7
History held since 29 May 2018